Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients

Background: Convalescent plasma is the only antibody based therapy currently available for COVID-19 patients. It has robust historical precedence and sound biological plausibility. Although promising, convalescent plasma has not yet been shown to be safe as a treatment for COVID-19. Methods: Thus, w...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:medRxiv
Autors principals: Joyner, Michael, Wright, R. Scott, Fairweather, DeLisa, Senefeld, Jonathon, Bruno, Katelyn, Klassen, Stephen, Carter, Rickey, Klompas, Allan, Wiggins, Chad, Shepherd, John RA, Rea, Robert, Whelan, Emily, Clayburn, Andrew, Spiegel, Matthew, Johnson, Patrick, Lesser, Elizabeth, Baker, Sarah, Larson, Kathryn, Ripoll Sanz, Juan, Andersen, Kylie, Hodge, David, Kunze, Katie, Buras, Matthew, Vogt, Matthew, Herasevich, Vitaly, Dennis, Joshua, Regimbal, Riley, Bauer, Philippe, Blair, Janis, van Buskirk, Camille, Winters, Jeffrey, Stubbs, James, Paneth, Nigel, Casadevall, Arturo
Format: Artigo
Idioma:Inglês
Publicat: Cold Spring Harbor Laboratory 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7274247/
https://ncbi.nlm.nih.gov/pubmed/32511566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.05.12.20099879
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars